Back to Annual Meeting
Back to Annual Meeting
|
Back to Annual Meeting
|
|
Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
5071.0: Wednesday, November 07, 2007: 8:30 AM-10:00 AM | ||||
Oral | ||||
| ||||
| The session focuses on the policy and program implications of factors associated with cervical cancer screening in the U.S., including factors associate with screening and challenges with screening programs and laws and policies mandating vaccination. One paper uses data from a 2002 survey to assess the relative impact of various factors (e.g. social conservatism, personal health practices and health system variables) on the likelihood of getting screened for cervical cancer in the US. This information is important because cervical cancer is preventable and treatable if detected early. Another paper describes the role of the Pap test for cervical cancer screening among women ages 30 and older and analyzes socioeconomic characteristics among women who have either not recently or have never received this cancer screening. One presenter analyzes state-level legislative data to identify states mandating insurance coverage for cervical cancer screening and treatment. The analysis addresses the extent to which insurers provide coverage in accordance with American Cancer Society guidelines and the emergence of laws requiring vaccination. Another panelist assesses cognitive and emotional responses to an HPV diagnosis among men. Male partners can play a critical role in cervical cancer prevention efforts. Understanding mens knowledge and appraisal processes concerning and HPV diagnosis may be part of addressing issues around disclosure of an HPV diagnosis, suggesting screening, getting vaccinated and decreasing risky sexual behaviors. | ||||
| Learning Objectives: To discuss the relative impact of various factors on the likelihood of getting screened for cervical cancer in the US. Analyze access and barriers to cervical cancer screening. List possible implications of new HPV vaccination policy guidelines on future cancer screening behaviors among women ages 30 and older. Identify states with laws requiring insurers to provide coverage for cervical cancer screening and treatment, including HPV screening and those with cervical cancer awareness resolutions. | ||||
| Moderator(s): | Carrisa Baker | |||
| 8:30 AM |  | Cognitive and emotional differences among HPV+ and HPV- men: Results of a pilot study of HPV in men in a natural history study Ellen Daley, PhD, Anna Giuliano, PhD, Julie Baldwin, PhD, Eric R. Buhi, MPH, PhD, CHES, Ji-Hyun Lee, PhD, Susan Vadaparampil, PhD, Martha Abrahamsen, MPH, Cheryl Vamos, MPH, Stephanie Kolar, MSPH, Rasheeta Chandler, RN, MS, Erica Anstey | ||
| 8:50 AM | | Research, policy, and results: The human papillomavirus vaccine and state efforts to reduce cervical cancer Carissa Baker, Jill Freudenwald, MA, Regina El Arculli, MA, Kerri M. Lowrey, JD, MPH | ||
| 9:10 AM | | Frequency of cervical cancer screenings among women (18-64 years) in the Philadelphia Metropolitan Area Nicole Dreisbach, BA, Allegra R. Gordon, MPH, Francine Axler, MPH, Lynne Kotranski, PhD, Gary Klein, PhD, Abdul Beraima, PhD | ||
| 9:30 AM | Social conservatism, reproductive health practices, and cervical cancer screening Lisa C. Gary, PhD, Lucy Annang, PhD | |||
| See individual abstracts for presenting author's disclosure statement and author's information. | ||||
| Organized by: | Population, Family Planning, and Reproductive Health | |||
| Endorsed by: | HIV/AIDS; Maternal and Child Health; Women's Caucus | |||
| CE Credits: | CME, Health Education (CHES), Nursing | |||
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA